Cargando…

Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients

PURPOSE: Most patients suffering from advanced lung cancer die within a few months. To exploit new therapy regimens we need better methods for the assessment of a therapy response. MATERIAL AND METHODS: In a pilot study we prospectively enrolled 36 patients with advanced NSCLC and SCLC (34 stage IV,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Bernd, Beyer, Julia, Dietrich, Dimo, Bork, Ines, Liebenberg, Volker, Fleischhacker, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326280/ https://www.ncbi.nlm.nih.gov/pubmed/25675432 http://dx.doi.org/10.1371/journal.pone.0118195

Ejemplares similares

Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
por: Schneider, Katja U, et al.
Publicado: (2011)

SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
por: Schmidt, Bernd, et al.
Publicado: (2010)

Cell-Free Methylated PTGER4 and SHOX2 Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients
por: Fleischhacker, Michael, et al.
Publicado: (2023)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)
por: Saltos, Andreas, et al.
Publicado: (2020)

SCLC-J1, a novel small cell lung cancer cell line
por: Ohara, Kazuo, et al.
Publicado: (2021)

Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors.
por: Paone, G., et al.
Publicado: (1997)

An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
por: Wei, Kanglai, et al.
Publicado: (2016)

Small Cell Lung Cancer (SCLC) Presenting as Acute Pancreatitis: The Role of Hypercalcemia
por: Tan, Jessica, et al.
Publicado: (2012)

Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes
por: Bebber, Christina M., et al.
Publicado: (2021)

A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)
por: Oronsky, Bryan, et al.
Publicado: (2022)

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites
por: Jung, Maria, et al.
Publicado: (2016)

Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
por: Bergheim, Julia, et al.
Publicado: (2018)

Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer
por: Feng, Hongxiang, et al.
Publicado: (2020)

DT-diaphorase activity in NSCLC and SCLC cell lines: a role for fos/jun regulation
por: Kepa, J K, et al.
Publicado: (1999)

Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1994)

The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC)
por: Men, Yu, et al.
Publicado: (2017)

Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
por: Ding, Xiao-Long, et al.
Publicado: (2022)

Tumor and host characteristics of small cell lung cancer (SCLC) in U.S. community oncology practice
por: Richards, Donald, et al.
Publicado: (2015)

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models
por: Salgia, Ravi, et al.
Publicado: (2018)

Tracheal polypoid combined small cell lung cancer (C‐SCLC): A case report
por: Testori, Alberto, et al.
Publicado: (2021)

Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring
por: Barchiesi, Vittoria, et al.
Publicado: (2021)

Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy
por: Zeng, Jiao, et al.
Publicado: (2023)

TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)
por: Messaritakis, Ippokratis, et al.
Publicado: (2017)

Variants in the 5′UTR reduce SHOX expression and contribute to SHOX haploinsufficiency
por: Babu, Deepak, et al.
Publicado: (2020)

SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures
por: Tlemsani, Camille, et al.
Publicado: (2020)

Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting
por: Lekic, Mirko, et al.
Publicado: (2012)

Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019)

Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
por: von Eiff, Damian, et al.
Publicado: (2020)

Non-neuroendocrine differentiation generates a ferroptosis-prone lipidome in small cell lung cancer (SCLC)
por: Bebber, Christina M., et al.
Publicado: (2021)

Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
por: Mercier, Stéphanie L., et al.
Publicado: (2022)

The Short-Stature Homeobox-Containing Gene (shox/SHOX) Is Required for the Regulation of Cell Proliferation and Bone Differentiation in Zebrafish Embryo and Human Mesenchymal Stem Cells
por: Yokokura, Tomoaki, et al.
Publicado: (2017)

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
por: Dietrich, Dimo, et al.
Publicado: (2013)

Expressing human SHOX in Shox2(SHOX KI)/(KI) mice leads to congenital osteoarthritis-like disease of the temporomandibular joint in postnatal mice
por: Liang, Wenna, et al.
Publicado: (2016)

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
por: Semaan, Alexander, et al.
Publicado: (2016)

A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
por: Cerny, T., et al.
Publicado: (1989)

A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom
por: Sambrook, R J, et al.
Publicado: (2001)

Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1992)

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
por: Lohinai, Zoltan, et al.
Publicado: (2016)

Determination of Risk Factors Related to Supraclavicular Recurrence for Limited-Stage Small Cell Lung Cancer (SCLC) Patients
por: Guan, Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rbkmk2sodeotsv8d1da64ihnf6